Parnassus Investments LLC Has $96.48 Million Holdings in CME Group Inc. $CME

Parnassus Investments LLC lifted its position in shares of CME Group Inc. (NASDAQ:CME) by 1.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 353,308 shares of the financial services provider’s stock after purchasing an additional 6,564 shares during the quarter. Parnassus Investments LLC’s holdings in CME Group were worth $96,481,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of CME. Empowered Funds LLC grew its holdings in shares of CME Group by 11.5% during the 1st quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock worth $2,660,000 after purchasing an additional 1,037 shares in the last quarter. Marshall Wace LLP boosted its stake in CME Group by 103.1% in the 2nd quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider’s stock valued at $1,018,000 after buying an additional 121,707 shares in the last quarter. Federated Hermes Inc. boosted its stake in CME Group by 1,325.2% in the 2nd quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider’s stock valued at $6,497,000 after buying an additional 21,918 shares in the last quarter. Nebula Research & Development LLC acquired a new stake in CME Group in the 2nd quarter valued at $992,000. Finally, The Manufacturers Life Insurance Company boosted its stake in CME Group by 2.6% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider’s stock valued at $79,344,000 after buying an additional 7,397 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Price Performance

CME Group stock opened at $262.18 on Friday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The firm has a market cap of $95.00 billion, a P/E ratio of 22.37, a P/E/G ratio of 2.95 and a beta of 0.21. The business’s fifty day moving average is $285.34 and its two-hundred day moving average is $288.20. CME Group Inc. has a 52 week low of $244.56 and a 52 week high of $329.16.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. The company had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The business’s revenue was up 14.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.80 earnings per share. Equities research analysts forecast that CME Group Inc. will post 12.28 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th will be paid a $1.30 dividend. The ex-dividend date of this dividend is Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a yield of 2.0%. CME Group’s payout ratio is currently 44.37%.

Analyst Ratings Changes

Several analysts recently commented on CME shares. The Goldman Sachs Group decreased their price target on CME Group from $275.00 to $267.00 and set a “sell” rating on the stock in a research note on Thursday, April 23rd. TD Cowen decreased their price target on CME Group from $340.00 to $323.00 and set a “buy” rating on the stock in a research note on Thursday, April 23rd. Deutsche Bank Aktiengesellschaft decreased their price target on CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a research note on Thursday, April 23rd. Keefe, Bruyette & Woods started coverage on CME Group in a research note on Wednesday, April 8th. They issued a “market perform” rating and a $305.00 price target on the stock. Finally, Rothschild & Co Redburn raised CME Group from a “neutral” rating to a “buy” rating and boosted their price target for the company from $316.00 to $323.00 in a research note on Thursday. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, CME Group has a consensus rating of “Moderate Buy” and a consensus price target of $305.71.

Key CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group launched Nasdaq CME Crypto Index futures, giving investors regulated exposure to a basket of major digital assets such as Bitcoin, Ethereum, Solana, XRP, Cardano, Chainlink, and Stellar. This could attract fresh institutional trading and hedging activity. CME Group Launches Crypto Index Futures Tracking Bitcoin, Solana and XRP
• Positive Sentiment: The company announced four new E-mini futures contracts tied to broad U.S. equity benchmarks, expanding its equity index franchise and potentially increasing trading volumes. CME Group to Expand Equity Index Suite with Launch of Four New E-mini Futures Contracts
• Positive Sentiment: CME also unveiled financially settled Micro E-mini S&P 500 and Nasdaq-100 options, which should broaden access for smaller traders and add another potential source of contract activity. CME Group to Launch New Financially-Settled Micro E-mini S&P 500 and Nasdaq-100 Options
• Positive Sentiment: CME said it will expand 24/7 trading for smaller WTI crude oil and gold contracts, a move that could improve market access and price discovery while boosting engagement in its commodities products. CME Group to Expand 24/7 Trading for WTI Crude Oil and Gold
• Positive Sentiment: CME entered an exclusive multi-year licensing deal with Morningstar to launch derivatives based on key Morningstar equity indexes, opening a new product line tied to more than $3 trillion in linked assets. CME Group and Morningstar Announce Exclusive Index Derivatives Licensing Agreement
• Neutral Sentiment: Analysts at Erste Group Bank slightly raised FY2026 earnings estimates for CME, but kept a Hold rating. That signals modestly improved expectations, though not a strong new bullish call.
• Neutral Sentiment: Shareholders maintained CME’s Class B governance structure, which removes uncertainty around a possible change but is unlikely to be a major near-term operating catalyst. CME Group Shareholders Maintain Class B Governance Structure
• Neutral Sentiment: Cardano futures on CME are nearing the six-month threshold that could help an ETF application qualify, but the potential benefit is indirect and still months away. SEC Clock Ticks as Cardano Futures Edge Toward ETF Qualification

Insiders Place Their Bets

In other CME Group news, insider Hilda Harris Piell sold 5,753 shares of the business’s stock in a transaction on Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the transaction, the insider owned 27,702 shares of the company’s stock, valued at approximately $8,438,860.26. The trade was a 17.20% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, General Counsel Jonathan L. Marcus sold 3,291 shares of the business’s stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total value of $1,097,120.67. Following the completion of the transaction, the general counsel directly owned 7,192 shares in the company, valued at approximately $2,397,597.04. This represents a 31.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 44,044 shares of company stock valued at $13,297,507. 0.30% of the stock is currently owned by corporate insiders.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.